drugset / Trial / NCT03415750

Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants

NCT03415750

Phase 4 Completed 20 enrolled Edoardo Melilli
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical study with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the maintenance phase.

Timeline

Start
2016-11
Primary completion
2020-05
Completion
2020-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule
Comparator Mycophenolate Mofetil Small molecule
Background Tacrolimus Small molecule

Indications

No indication recorded.